Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Steven MenezDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-2490-025
Kathleen F KerrDepartment of Biostatistics, University of Washington, Seattle, Washington.ORCID 0000-0002-6438-9583
Si ChengDepartment of Biostatistics, University of Washington, Seattle, Washington.ORCID 0000-0003-4353-4259
David HuDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0001-9306-4705
Heather Thiessen-PhilbrookDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-2067-0514
Dennis G MoledinaSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.ORCID 0000-0002-9537-9038
Sherry G MansourSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Alan S GoDivision of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, California.ORCID 0000-0001-9109-0811
T Alp IkizlerDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee.ORCID 0000-0002-5717-4218
James S KaufmanDivision of Nephrology, New York University School of Medicine, VA New York Harbor Healthcare System, New York, New York.ORCID 0000-0002-6778-4167
Paul L KimmelDivision of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Jonathan HimmelfarbDivision of Nephrology, Department of Medicine, Kidney Research Institute, University of Washington, Seattle, Washington.ORCID 0000-0002-3319-1224
Steven G CocaDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Chirag R ParikhDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0001-9051-7385
Funding
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI PREISIG, PATRICIA A · 2008 to 2022
$16.8M
Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3M
Data Coordinating Center for the Natural History of AKI ConsortiumU01DK082183 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHINCHILLI, VERNON M · 2008 to 2018
$9.7M
Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft OutcomesR01DK093770 · NIDDK · YALE UNIVERSITY · PI Chirag R Parikh · 2012 to 2026
$9.5M
Vanderbilt O'Brien Kidney Center - Core D - Clinical and Translational CoreP30DK114809 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DE CAESTECKER, MARK P. · 2017 to 2021
$5.9M
Progression of Acute Kidney Injury to Chronic Kidney DiseaseU01DK082185 · NIDDK · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2008 to 2017
$5.1M
Impact of Acute Kidney Injury on Kidney Disease ProgressionU01DK082192 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI IKIZLER, TALAT ALP · 2008 to 2018
$5.0M
Post-Discharge Nephrology Follow-up for Improved OutcomesU01DK129984 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Chirag R Parikh · 2021 to 2026
$4.2M
Prospective Evaluation of Acute Kidney Injury (PEAK) CohotU01DK082223 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2008 to 2018
$4.0M
Macrophage Function in Kidney RepairR01DK093771 · NIDDK · YALE UNIVERSITY · PI LLOYD G CANTLEY · 2012 to 2026
$3.9M
Acute kidney injury among patients with chronic kidney diseaseR01DK114014 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSU, CHI-YUAN · 2018 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors. · full record | OpenQuestion